In today's article we are going to delve into the topic of Ciclometasone, an aspect that has been debated for a long time. Ciclometasone is a topic that has generated great interest among experts and fans alike, and is crucial to understanding its impact on different aspects of modern society. Throughout this article, we will analyze the different approaches that have been taken in relation to Ciclometasone, as well as their implications on a personal, social and global level. Additionally, we will explore some of the most recent research on Ciclometasone and discuss possible implications for the future. Ultimately, this article aims to offer a complete and updated view on Ciclometasone, with the aim of providing our readers with a deeper understanding of this very relevant topic.
Clinical data | |
---|---|
Trade names | Cycloderm, Telocort |
Other names | Cyclomethasone; RIB-222; 9α-Chloro-11β,17α,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-cyclo- hexyl]carboxylate; 21-cyclo- hexyl]carbonyl]oxy]-9α-chloro-11β,17α-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C32H44ClNO7 |
Molar mass | 590.15 g·mol−1 |
3D model (JSmol) | |
| |
|
Ciclometasone (brand names Cycloderm, Telocort) is a synthetic glucocorticoid corticosteroid which is marketed in Italy.